The decreased MHCIIloCD206hi macrophage fraction in PMX53 and olaparib treated mice as well as an increase in CD8 T cells likely contributed to the tumor growth inhibition induced by the combination of PMX53 and olaparib in both T127 and T22 in co-transplantation models. The gene discussed is CD8A; the disease is neoplasm.